Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
Kylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes, Louise E Donnelly Airway Disease Section, National Heart and Lung Institute, Dovehouse Street, Imperial College London, London, UK Background: Inhaled corticosteroid use is associated with increased rates of pneumonia in COPD p...
Main Authors: | Belchamber KBR, Thomas CMR, Dunne AE, Barnes PJ, Donnelly LE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/comparison-of-fluticasone-propionate-and-budesonide-on-copd-macrophage-peer-reviewed-article-COPD |
Similar Items
-
Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01) -
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study
by: Iseul Yu, et al.
Published: (2022-07-01) -
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
by: Choi JH, et al.
Published: (2021-11-01) -
Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study
by: P. Kiruba Shankari, et al.
Published: (2021-11-01) -
Comparison of the efficacy of combined budesonide and fexofenadine versus combined fluticasone propionate and fexofenadine on the expression of class-4 semaphorins and their receptors in the peripheral blood cells of patients with allergic rhinitis
by: Gelayol Asadi, et al.
Published: (2024-01-01)